囊肿切开联合或不联合纤维蛋白凝块清除治疗糖尿病视网膜病变难治性黄斑囊样水肿的长期效果
回顾性分析30例糖尿病视网膜病变难治性黄斑囊样水肿患者,行囊肿切开联合或不联合纤维蛋白凝块清除,随访12个月。术后最佳矫正视力与黄斑中心凹厚度均较术前显著改善,黄斑中心敏感度无显著变化,7眼复发。
要点
- 术后12个月最佳矫正视力(logMAR 0.33±0.25)较术前(0.45±0.33)显著改善(P<0.01)。
- 术后12个月黄斑中心凹厚度(300.3±99.0 μm)较术前(565.6±198.7 μm)显著降低(P<0.01)。
- 随访期间7/30眼黄斑囊样水肿复发。
核心结论
- 囊肿切开联合或不联合纤维蛋白凝块清除可能是糖尿病视网膜病变难治性黄斑囊样水肿有前景的治疗选择。
研究设计与样本
- 回顾性分析30例(30眼)糖尿病视网膜病变难治性黄斑囊样水肿患者的医疗记录,所有患者术后随访12个月。
主要发现
- 术后12个月最佳矫正视力(logMAR)为0.33±0.25(Snellen等效20/42),术前为0.45±0.33(Snellen等效20/56),差异有统计学意义(P<0.01)。
- 术后12个月黄斑中心敏感度(微视野,dB)为24.1±4.0,术前为24.0±4.9,差异无统计学意义(P=0.75)。
- 术后12个月黄斑中心凹厚度(OCT,μm)为300.3±99.0,术前为565.6±198.7,差异有统计学意义(P<0.01)。
- 随访期间30眼中7眼黄斑囊样水肿复发。
- 行纤维蛋白凝块清除的患者(n=16)术前OCT黄斑囊样腔反射率显著高于未行清除的患者(n=14)(P<0.04)。
临床怎么用
- 对于糖尿病视网膜病变难治性黄斑囊样水肿,可考虑囊肿切开联合或不联合纤维蛋白凝块清除以改善视力和黄斑厚度。
- 术前OCT黄斑囊样腔反射率较高的患者可能更适合联合纤维蛋白凝块清除。
- 术后需随访监测黄斑囊样水肿复发。
局限性
- 回顾性研究,样本量较小(30眼),未设对照组,证据等级有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To show the long-term effect of cystotomy with or without fibrinogen clot removal for refractory cystoid macular edema secondary to diabetic retinopathy. METHODS: Retrospective analyses of the medical records of 30 eyes of 30 patients with refractory cystoid macular edema secondary to diabetic retinopathy who had followed up for 12 months after the surgery were performed. RESULTS: There were 15 men and 15 women. The mean ± SD age was 68.4 ± 7.9 years. The best-corrected visual acuity (logarithm of the minimal angle of resolution) at 12 months after the surgery (0.33 ± 0.25, Snellen equivalent, 20/42) was statistically better than the preoperative best-corrected visual acuity (0.45 ± 0.33, Snellen equivalent, 20/56) (P < 0.01). The central sensitivity on microperimetry (dB) was not statistically changed between preoperatively (24.0 ± 4.9) and 12 months after the surgery (24.1 ± 4.0) (P = 0.75). The central retinal thickness on optical coherence tomography (μm) at 12 months after the surgery (300.3 ± 99.0) was statistically improved compared with the preoperative central retinal thickness (565.6 ± 198.7) (P < 0.01). During the follow-up period, cystoid macular edema relapsed in seven of 30 eyes. The preoperative cystoid cavity reflectivity on optical coherence tomography in patients with fibrinogen clot removal (n = 16) was significantly higher than that in patients without fibrinogen clot removal (n = 14) (P < 0.04). CONCLUSION: The cystotomy with or without fibrinogen clot removal may be a promising treatment option for refractory cystoid macular edema secondary to diabetic retinopathy.
引用
- Imai H, Tetsumoto A, Yamada H, et al. LONG-TERM EFFECT OF CYSTOTOMY WITH OR WITHOUT THE FIBRINOGEN CLOT REMOVAL FOR REFRACTORY CYSTOID MACULAR EDEMA SECONDARY TO DIABETIC RETINOPATHY. Retina. 2021. PMID: 32732609. doi:10.1097/IAE.0000000000002921
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。